2023
Pediatric HIV Disclosure Intervention Improves Immunologic Outcome at 48 Weeks: The Sankofa Trial Experience
Shabanova V, Emuren L, Gan G, Antwi S, Renner L, Amissah K, Kusah J, Lartey M, Reynolds N, Paintsil E. Pediatric HIV Disclosure Intervention Improves Immunologic Outcome at 48 Weeks: The Sankofa Trial Experience. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2023, 94: 371-380. PMID: 37643414, PMCID: PMC10617661, DOI: 10.1097/qai.0000000000003292.Peer-Reviewed Original ResearchConceptsHIV disclosure interventionsVirologic outcomesCD4 percentWeek 48HIV statusIntervention groupHIV disclosureDisclosure interventionDetectable viral loadWorld Health OrganizationAntiretroviral therapyImmunologic outcomesClinical outcomesIntervention armViral loadControl armClinical trialsTrial experienceSecondary analysisDisclosure statusHealth OrganizationCategorical variablesWeeksLinear mixed modelsBaseline
2018
Desire for improved disclosure, community and bonding among young adults with perinatally acquired HIV
Wang’ondu R, Samuels S, Andiman W, Paintsil E, Barakat L, Langs-Barlow A. Desire for improved disclosure, community and bonding among young adults with perinatally acquired HIV. Cogent Social Sciences 2018, 4: 1463816. DOI: 10.1080/23311886.2018.1463816.Peer-Reviewed Original ResearchHuman immunodeficiency virus programmeNumber of patientsHealth care providersYears of ageBiological mothersFear of stigmaHIV statusHIV knowledgeHIV disclosureHigh-income countriesCare providersPHIVPatientsYoung adultsBrief Resilience ScaleComprehensive interviewFeelings of isolationResilience ScaleImproved disclosureSharing of experiencesMothersAdulthoodLived experienceMedicationsHIV